终末期肝硬化,End-stage hepatocirrhosis
1)End-stage hepatocirrhosis终末期肝硬化
英文短句/例句
1.Treatment of End-staged Liver Cirrhosis with Auxiliary Liver Transplantation in Rats;辅助性肝移植治疗大鼠终末期肝硬化的实验研究
2.Analysis of Prognosis in Patients with Decompensated Cirrhosis by the Model for End-stage Liver Disease and Its Longitudinal Modifications;终末期肝病模型及其变化对失代偿期肝硬化患者的预后分析
3.The delta value of model of end stage liver disease in predicting the prognosis of patients with decompensated cirrhosis终末期肝病模型评分差值对失代偿期肝硬化患者预后评估的价值
4.Values of end-stage liver disease model in assessment of prognosis in patients with decompensated liver cirrhosis终末期肝病模型评估失代偿期肝硬化患者预后的价值
5.MELD scores and prognosis of patients with decompensated liver cirrhosis treated by traditional Chinese medicine终末期肝病模型在中医药治疗失代偿期肝硬化患者时的应用价值
6.The analysis of prognosis of patients with decompensated liver cirrhosis using the criterion of the model for end-stage liver disease and Child-Pugh grading终末期肝病模型及Child-Pugh分级对失代偿期肝硬化患者的预后分析
7.The clinical significance of serum VEGF and MELD in patients with liver cirrhosis肝硬化患者VEGF水平和终末期肝病模型评分的临床意义
8.Changes of modelfor end-stage liver disease score in patients with cirrhosis by lipo prostaglandin El前列腺素E1脂微球载体对失代偿期肝硬化患者终末期肝病模型评分的影响
9.Analysis on prognosis of decompensated liver cirrhotic patients using Model for End-stage Liver Disease score and Child-Pugh score终末期肝病模型评分与Child-Pugh评分对失代偿期肝硬化患者的预后分析
10.Correlation between Advanced Glycosylation End Products and Carotid Atherosclerosis in Elderly Patients with Essential Hypertension晚期糖基化终末产物与老年高血压病颈动脉粥样硬化关系的研究
11.Post-transplant Diabetes Mellitus in HBV Related Recipients乙肝相关性终末期肝病肝移植术后糖尿病分析
12.Maintenance of Hemodialysis Patients with End-stage Renal Failure Atherosclerosis Correlation Between Serum HGF终末期肾衰维持血透患者动脉粥样硬化与血清HGF相关性研究
13.Perioperative protection of organs during liver transplantation in patients with advanced liver disease终末期肝病肝移植治疗围术期器官保护
14.Association of the clinical features with pathology at end-stage liver disease终末期肝病患者临床特点与病理联系
15.Evaluation Studies of MELD to Asses the Prognosis of Patients with Severe Hepatitis;终末期肝病模型（MELD）对重型肝炎预后评价研究
16.Clinical features and outcome of pediatric liver transplantation小儿终末期肝病肝移植术式选择(附15例报告)
17.Consummating of the model for end stage liver disease and its prognostic value in liver transplantation终末期肝病模型评分的完善与肝移植预后
18.Contrastive Study on Hepatitis B Virus Transcript of Liver Tissue and Serum in Patients with End-stage Liver Disease;终末期肝病患者肝组织和血清中乙型肝炎病毒转录体的对照研究
相关短句/例句
End-stage liver disease终末期肝病
1.Advances in the study on malnutrition in end-stage liver disease终末期肝病营养不良的研究进展
3)end-stage liver disease secondary to hepatitis B乙肝终末期肝病
1.The outcome of liver transplantation forend-stage liver disease secondary to hepatitis B is remarkably impacted by recurrent infection and subsequent allograft failure.乙肝终末期肝病患者肝脏移植术后乙肝复发是影响患者长期存活的重要因素。
4)model for end-stage liver disease终末期肝病模型
1.A retrospective analysis of prognosis on patients with severe hepatitis using themodel for end-stage liver disease;重型肝炎的终末期肝病模型预后回顾性分析
2.Objective To investigate the predictive value ofmodel for end-stage liver disease(MELD) for the evaluation of the short-time outcome of patients underwent liver transplantation.目的探讨术前终末期肝病模型(model for end-stage liver disease,MELD)评分在肝移植治疗终末期肝病早期预后中的预测价值。
5)benign end-stage liver disease良性终末期肝病
1.Pretransplantation MELD score predicts short-term survival of patients withbenign end-stage liver disease post-liver transplantation;MELD评分预测良性终末期肝病肝移植术后短期生存率的初步研究
6)Model for end-stage liver disease(MELD)终末期肝病模型
1.Objective: To investigate the relationship between the model for end-stage liver disease(MELD) and Child-Turcotte-Pugh(CTP) scoring,and the prognosis of patients with decompensated liver cirrhosis.目的:研究终末期肝病模型(MELD)与Child-Turcotte-Pugh(CTP)评分系统和肝硬化失代偿期患者短期(3个月)预后的关系。
延伸阅读
肝硬化性肾小球硬化肝硬化性肾小球硬化hepatocirrhotic glomerulosclerosis肝脏病时，肠道内抗原通过侧支循环进入体循环，激发抗体生成，导致免疫复合物性肾炎，最终形成肾小球硬化。多见于肝硬化期，临床表现以肝病表现为主，肾脏病表现为次。晚期可有肝肾衰竭。
